IMF Videos Search Content For Healthcare Professional (76) Healthcare Provider (75) Care Partner (65) Patient (65) Series - Any - ASCO/EHA (31) ASH (30) Ask Dr. Durie (16) Community Workshops (3) Emerging Therapies (12) Facebook Live (6) Health Equity (4) IMWG (3) Living Well with Myeloma (3) Myeloma in a Minute (2) Myeloma Made Simple (6) Myeloma University (9) Q&A (6) Recent News and Developments (2) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (88) High-Risk Myeloma (38) High-risk Smoldering Myeloma (17) Late Relapse (4–6 Lines of Therapy) (101) MGUS (5) Newly Diagnosed (Pre-Treatment or First Treatment) (24) Smoldering Myeloma (13) Types of Therapy Immunomodulatory drugs (IMiDs) (31) Immunotherapies (CAR T; BiTE, etc.) (97) Monoclonal antibodies (33) Proteasome inhibitors (23) Stem cell transplant (24) Steroids (20) Supportive Care (36) Year Published 2026 (18) 2025 (22) 2024 (35) 2023 (39) 2022 (4) 2021 (4) 2020 (3) 2019 (2) 2018 (1) 2017 (1) 2016 (4) 2015 (2) Trusted Voices Dr. Joseph Mikhael (35) Dr. Brian GM Durie (15) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Donna Catamero, ANP-BC, OCN, CCRC (3) Dr. María-Victoria Mateos (2) Dr. Saad Usmani (2) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Coordinating Bispecific Antibodies for Multiple Myeloma: A Patient’s Guide May 29, 2025 Myeloma Made Simple MMR Vaccine Safety & CAR‑T Eligibility, and More: Top 10 Myeloma Patient Q&A May 8, 2025 Q&A CAR T-Cell Therapy Explained in Under 1 Minute | Multiple Myeloma Treatment Breakthroughs April 16, 2025 Myeloma in a Minute Q&A: Ask Me Anything About Myeloma with Dr. Saad Usmani March 10, 2025 Facebook Live IMWG Conference Series: Making Sense of Treatment ASH 2024 December 18, 2024 IMWG Regional Myeloma Community Workshop — Online! November 12, 2024 Community Workshops 5 Multiple Myeloma Research Highlights: 2024 International Myeloma Society Meeting | For Patients October 17, 2024 Emerging Therapies Myeloma Causes, Side Effects, Light Chain Levels, Darzalex, IVIG, & More: Answering Your Myeloma Questions October 14, 2024 Q&A Impact of Relapses, Stem Cell Transplants, Diet and Nutrition: Answering Your Myeloma Questions September 19, 2024 Q&A Key Multiple Myeloma Abstracts Presented at 2024 ASCO and EHA Meeting August 1, 2024 ASCO/EHA Evaluation of elranatamab vs EPd, PVd, or Kd in patients with relapsed or refractory multiple myeloma and prior anti-CD38–directed therapy: MagnetisMM-32 July 31, 2024 ASCO/EHA MagnetisMM-30, a Phase 1b Study of ELRA and IBER Combination in Relapsed Refractory Multiple Myeloma July 15, 2024 ASCO/EHA Load More
